Botanical species · safety record

Plantago ovata

The EFSA Compendium of Botanicals holds 5 constituent measurements and 2 adverse-effect records for Plantago ovata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Plantago ovata Forssk.

5Constituent measurements

2Safety records

4Cited sources

702Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 702 licensed products naming Plantago ovata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh

Source material stated

Flowers
Hull
Husk
Husk (dry)
Husk powder
Husks and seeds
Leaves
Musk

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cardiac glycosides	Seed	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Coumarins	Aerial part of plants	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Furanocoumarins	Aerial part of plants	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Tannic acid	Seed	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Seed	Solvent extraction	17.9 Percent	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Seed	Solvent extraction	—	In vitro	Resolve DOI
Reproductive	Urogenital	Seed	—	—	Case report	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Abbas, Mazhar., Shahid, Muhammad., Iqbal, Munawar., Anjum, Fozia., Sharif, Sumaira., Ahmed, Sohail., Pirzada, Tajnees. Antitermitic activity and phytochemical analysis of fifteen medicinal plant seeds. Journal of Medicinal Plants Research, 2013, p. 1608-1617.
Palanuvej, C., Hokputsa, S., Tunsaringkarn, T., Ruangrungsi, N. In vitro glucose entrapment and alpha-glucosidase inhibition of mucilaginous substances from selected Thai medicinal plants. Scientia pharmaceutica, 2009, vol. 77, no. 4, p. 837-849. DOI
Shah, Ghulam Mujtaba., Khan, Mir Ajab., Ahmad, Mushtaq., Zafar, Muhammad., Khan, Aftab Ahmed. Observations on antifertility and abortifacient herbal drugs. African journal of biotechnology, 2009, vol. 8, no. 9, p. 1959-1964.
Grace, Mary H., Nofal, Salwa M. Pharmaco-chemical investigations of Plantago ovata aerial parts. Bulletin of the faculty of pharmacy (cairo university), 2001, p. 345-352.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature